KRAS and colonic neoplasm: In subsequent studies, we found that among wild-type KRAS colon cancer cells, those harbouring active mutations in BRAF were even more resistant to AUY922-induced apoptosis than cells with wild-type BRAF (Figure 1A and 1B).